Sam68 Allows Selective Targeting of Human Cancer Stem Cells

被引:41
作者
Benoit, Yannick D. [1 ]
Mitchell, Ryan R. [1 ]
Risueno, Ruth M. [1 ]
Orlando, Luca [1 ]
Tanasijevic, Borko [1 ]
Boyd, Allison L. [1 ]
Aslostovar, Lili [1 ,2 ]
Salci, Kyle R. [2 ]
Shapovalova, Zoya [1 ]
Russell, Jennifer [1 ]
Eguchi, Masakatsu [3 ]
Golubeva, Diana [2 ]
Graham, Monica [1 ]
Xenocostas, Anargyros [4 ]
Trus, Michael R. [5 ]
Foley, Ronan [5 ]
Leber, Brian [5 ]
Collins, Tony J. [1 ]
Bhatia, Mickie [1 ,2 ]
机构
[1] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Fac Hlth Sci, 1280 Main St West,MDCL 5029, Hamilton, ON L8S 4L8, Canada
[2] McMaster Univ, Fac Hlth Sci, Dept Biochem & Biomed Sci, 1280 Main St West, Hamilton, ON L8S 4L8, Canada
[3] Theriac Pharmaceut Corp, Res Inst, 600 Broadway,Suite 580 Fl 5, Seattle, WA 98122 USA
[4] Univ Western Ontario, Schulich Sch Med, Dept Med, Div Hematol, London, ON N6A 3K7, Canada
[5] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada
来源
CELL CHEMICAL BIOLOGY | 2017年 / 24卷 / 07期
关键词
RNA-BINDING PROTEIN; SMALL-MOLECULE INHIBITOR; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; WNT/BETA-CATENIN; HEMATOPOIETIC STEM; CBP; PHOSPHORYLATION; TRANSFORMATION; PROLIFERATION;
D O I
10.1016/j.chembiol.2017.05.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Targeting of human cancer stem cells (CSCs) requires the identification of vulnerabilities unique to CSCs versus healthy resident stem cells (SCs). Unfortunately, dysregulated pathways that support transformed CSCs, such as Wnt/beta-catenin signaling, are also critical regulators of healthy SCs. Using the ICG-001 and CWP family of small molecules, we reveal Sam68 as a previously unappreciated modulator of Wnt/b-catenin signaling within CSCs. Disruption of CBP-beta-catenin interaction via ICG-001/CWP induces the formation of a Sam68-CBP complex in CSCs that alters Wnt signaling toward apoptosis and differentiation induction. Our study identifies Sam68 as a regulator of human CSC vulnerability.
引用
收藏
页码:833 / +
页数:21
相关论文
共 58 条
  • [1] WNT signalling pathways as therapeutic targets in cancer
    Anastas, Jamie N.
    Moon, Randall T.
    [J]. NATURE REVIEWS CANCER, 2013, 13 (01) : 11 - 26
  • [2] The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth
    Arensman, Michael D.
    Telesca, Donatello
    Lay, Anna R.
    Kershaw, Kathleen M.
    Wu, Nanping
    Donahue, Timothy R.
    Dawson, David W.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (10) : 2303 - 2314
  • [3] SUMO modification of Sam68 enhances its ability to repress cyclin D1 expression and inhibits its ability to induce apoptosis
    Babic, I.
    Cherry, E.
    Fujita, D. J.
    [J]. ONCOGENE, 2006, 25 (36) : 4955 - 4964
  • [4] Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases
    Bedford, David C.
    Kasper, Lawryn H.
    Fukuyama, Tomofusa
    Brindle, Paul K.
    [J]. EPIGENETICS, 2010, 5 (01) : 9 - 15
  • [5] An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
    Ben-Porath, Ittai
    Thomson, Matthew W.
    Carey, Vincent J.
    Ge, Ruping
    Bell, George W.
    Regev, Aviv
    Weinberg, Robert A.
    [J]. NATURE GENETICS, 2008, 40 (05) : 499 - 507
  • [6] Molecular Pathways: Epigenetic Modulation of Wnt-Glycogen Synthase Kinase-3 Signaling to Target Human Cancer Stem Cells
    Benoit, Yannick D.
    Guezguez, Borhane
    Boyd, Allison L.
    Bhatia, Mickie
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (21) : 5372 - 5378
  • [7] The RNA-binding protein Sam68 is a multifunctional player in human cancer
    Bielli, Pamela
    Busa, Roberta
    Paola Paronetto, Maria
    Sette, Claudio
    [J]. ENDOCRINE-RELATED CANCER, 2011, 18 (04) : R91 - R102
  • [8] Sumoylation Pathway Is Required to Maintain the Basal Breast Cancer Subtype
    Bogachek, Maria V.
    Chen, Yizhen
    Kulak, Mikhail V.
    Woodfield, George W.
    Cyr, Anthony R.
    Park, Jung M.
    Spanheimer, Philip M.
    Li, Yingyue
    Li, Tiandao
    Weigel, Ronald J.
    [J]. CANCER CELL, 2014, 25 (06) : 748 - 761
  • [9] Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
    Bonnet, D
    Dick, JE
    [J]. NATURE MEDICINE, 1997, 3 (07) : 730 - 737
  • [10] The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs
    Bossis, Guillaume
    Sarry, Jean-Emmanuel
    Kifagi, Chamseddine
    Ristic, Marko
    Saland, Estelle
    Vergez, Francois
    Salem, Tamara
    Boutzen, Helena
    Baik, Hayeon
    Brockly, Frederique
    Pelegrin, Mireia
    Kaoma, Tony
    Vallar, Laurent
    Recher, Christian
    Manenti, Stephane
    Piechaczyk, Marc
    [J]. CELL REPORTS, 2014, 7 (06): : 1815 - 1823